Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 placebo-controlled trial of Avidekel cannabis oil for behavioral disturbances in severe dementia
MOH_2018-07-11_002506Phase 2Recruiting
- Sponsor
- TO Pharma
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Dementia comparing Avidekel cannabis oil with Placebo oil (2 arms). Primary endpoint: Agitation and aggression severity. Started Aug 2016; status: recruiting.
02
Drugs
Avidekel
03
Conditions
Dementia
Beyond the preview
Go deeper on MOH_2018-07-11_002506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-07-11_002506.